{
    "clinical_study": {
        "@rank": "67291", 
        "acronym": "DPE", 
        "arm_group": [
            {
                "arm_group_label": "No frequent exacerbators", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients without exacerbations: 0 or 1 that did not required hospitalization in the previous year.\nInterventions:\nSpirometry\nEmogas analysis\nModified Borg Dyspnea Scale\nCO Exhaled breath\nP01\nFeNO"
            }, 
            {
                "arm_group_label": "Frequent exacerbators", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients with frequent exacerbations: \u22652 or \u22651 if it required hospitalization in the previous year.\nInterventions:\nSpirometry\nEmogas analysis\nModified Borg Dyspnea Scale\nCO Exhaled breath\nP01\nFeNO"
            }
        ], 
        "brief_summary": {
            "textblock": "The perception of breathlessness varies significantly among COPD patients with similar\n      severity of airflow limitation; those with poorer perception report less exacerbations as\n      compared to those with frequent exacerbations.\n\n      Cross-sectional comparison of breathlessness perception in COPD patients with frequent\n      exacerbations  or without frequent exacerbations.\n\n      To assess \"Breathlessness Perception\" the investigators will increase the ventilatory demand\n      of the patients by CO2-rebreathing method."
        }, 
        "brief_title": "Dyspnea in COPD: Relationship With Exacerbations Frequency", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Dyspnea", 
        "condition_browse": {
            "mesh_term": "Dyspnea"
        }, 
        "detailed_description": {
            "textblock": "The perception of breathlessness varies between individuals. This is a well-established\n      concept in asthma, but mostly unexplored in COPD; the relationship between airflow\n      limitation (FEV1, % ref.) and breathlessness (mMRC) is weak.\n\n      The perception of breathlessness varies significantly among COPD patients with similar\n      severity of airflow limitation; those with poorer perception report less exacerbations as\n      compared to those with frequent exacerbations.\n\n      It is a cross-sectional comparison of breathlessness perception in COPD patients with\n      frequent exacerbations (\u22652 or \u22651 with hospitalization in the previous year) or without\n      frequent exacerbations (0 or 1 without hospitalization in the previous year).\n\n      To assess \"Breathlessness Perception\" the investigators will increase the ventilatory demand\n      of the patients by CO2-rebreathing method. CO2 rebreathing test will be conducted to\n      evaluate the acute ventilatory response to CO2 inhalation used to estimate central\n      chemoreceptor responsiveness in patients with the obstructive pulmonary disease.\n\n      Simple descriptive statistics (unpaired T-test) and correlation analysis (bivariate and\n      multivariate) will be used to analyze results."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with diagnosis of COPD (Gold 2 or 3 or 4)\n\n          -  >2 months from last exacerbation and no change in therapy\n\n        Exclusion Criteria:\n\n          -  patients on regular sedative drugs\n\n          -  patients with neuromuscular diseases\n\n          -  patients with respiratory failure and/or in long-term oxygen therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02113839", 
            "org_study_id": "DysPerEx"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "No frequent exacerbators", 
                    "Frequent exacerbators"
                ], 
                "description": "Before re-breathing (if the patient not performed one 6 months in advance).", 
                "intervention_name": "Spirometry", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "FEV1", 
                    "FVC", 
                    "FEV1/FVC", 
                    "VC", 
                    "TLC", 
                    "Rwc", 
                    "DLCO", 
                    "DLCO/VA", 
                    "Ventilation (VE)", 
                    "Inspiratory capacity (IC)"
                ]
            }, 
            {
                "arm_group_label": [
                    "No frequent exacerbators", 
                    "Frequent exacerbators"
                ], 
                "description": "In current smokers of both arms to confirm that the patient has not smoked in the past three hours and to asses the smoking status (heavy, moderate, light).", 
                "intervention_name": "CO Exhaled breath", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "CO (ppm)", 
                    "COHb (%)"
                ]
            }, 
            {
                "arm_group_label": [
                    "No frequent exacerbators", 
                    "Frequent exacerbators"
                ], 
                "description": "P01 is the negative airway pressure generated during the \ufb01rst 100 ms of an occluded inspiration. It's an estimation of the neuromuscular drive to breathe.", 
                "intervention_name": "P01", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "No frequent exacerbators", 
                    "Frequent exacerbators"
                ], 
                "description": "The measurement of fraction of exhaled nitric oxide during exacerbations of COPD is higher than normal.", 
                "intervention_name": "FeNO", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Dyspnea perception", 
            "COPD", 
            "Exacerbations", 
            "CO2 rebreathing test"
        ], 
        "lastchanged_date": "April 14, 2014", 
        "location": {
            "contact": {
                "email": "iblanco2@clinic.ub.es", 
                "last_name": "Isabel Blanco Vich, MD, PhD", 
                "phone": "+34 649539835"
            }, 
            "facility": {
                "address": {
                    "city": "Barcelona", 
                    "country": "Spain", 
                    "state": "BCN", 
                    "zip": "08036"
                }, 
                "name": "Hospital Cl\u00ednic"
            }, 
            "investigator": [
                {
                    "last_name": "Isabel Blanco Vich, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Alvar G Agust\u00ed, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Giulia Scioscia, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Felip Burgos, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Breathlessness Perception in COPD: Relationship With Exacerbation Frequency", 
        "overall_contact": {
            "email": "iblanco2@clinic.ub.es", 
            "last_name": "Isabel Blanco Vich, MD, PhD", 
            "phone": "+34 649539835"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital Cl\u00ednic", 
                "last_name": "Isabel Blanco Vich, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Cl\u00ednic", 
                "last_name": "Alvar G Agust\u00ed, MD, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The negative airway pressure generated during the \ufb01rst 100 ms of an occluded inspiration, which is an estimation of the neuromuscular drive to breathe. (P01 )", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "reference": [
            {
                "PMID": "19558002", 
                "citation": "Davis SQ, Permutt Z, Permutt S, Naureckas ET, Bilderback AL, Rand CS, Stein BD, Krishnan JA. Perception of airflow obstruction in patients hospitalized for acute asthma. Ann Allergy Asthma Immunol. 2009 Jun;102(6):455-61. doi: 10.1016/S1081-1206(10)60117-2."
            }, 
            {
                "PMID": "16938447", 
                "citation": "Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M. Patient's perception of exacerbations of COPD--the PERCEIVE study. Respir Med. 2007 Mar;101(3):453-60. Epub 2006 Aug 30."
            }, 
            {
                "PMID": "10843984", 
                "citation": "Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000 May;117(5 Suppl 2):398S-401S. Review."
            }, 
            {
                "PMID": "10806163", 
                "citation": "Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 May;161(5):1608-13."
            }, 
            {
                "PMID": "10543270", 
                "citation": "Agust\u00ed AG, Villaverde JM, Togores B, Bosch M. Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 1999 Sep;14(3):523-8."
            }, 
            {
                "PMID": "17507545", 
                "citation": "Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. Epub 2007 May 16. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02113839"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Clinic of Barcelona", 
            "investigator_full_name": "Isabel Blanco", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "10-point subjective scoring system, in which a patient rates his/her effort of exertion.", 
                "measure": "Borg scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Fractional exhaled nitric oxide (FeNO)", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "The sum of inspiratory reserve volume and tidal volume.", 
                "measure": "Inspiratory capacity (IC)", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Ventilation at rest", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Testing for Carbon Monoxide in exhaled breath in current smokers.", 
                "measure": "CO exhaled test", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }
        ], 
        "source": "Hospital Clinic of Barcelona", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital Clinic of Barcelona", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}